BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Diagnosis
95 results:

  • 1. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 2. [Microsatellite instability in gastric cancer is a predictor of a favorable prognosis].
    Danilova NV; Chayka AV; Khomyakov VM; Oleynikova NA; Andreeva YY; Malkov PG
    Arkh Patol; 2022; 84(6):5-15. PubMed ID: 36469712
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bilateral pleural effusion associated with atezolizumab in a patient with Lynch syndrome-related urothelial carcinoma: a case report.
    Yhim HY; Jeon SY; Lee CH; Lee NR
    Ann Palliat Med; 2022 Jun; 11(6):2162-2169. PubMed ID: 34328007
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric cancer.
    Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
    JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
    Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
    Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comprehensive analysis of germline mutations in northern Brazil: a panel of 16 genes for hereditary cancer-predisposing syndrome investigation.
    Vidal AF; Ferraz RS; El-Husny A; Silva CS; Vinasco-Sandoval T; Magalhães L; Raiol-Moraes M; Barra WF; Pereira CLBL; de Assumpção PP; de Brito LM; Vialle RA; Santos S; Ribeiro-Dos-Santos Â; Ribeiro-Dos-Santos AM
    BMC Cancer; 2021 Apr; 21(1):363. PubMed ID: 33827469
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Lynch syndrome-associated repeated stroke with MLH1 frame-shift mutation.
    Zhang M; Yang H; Chen Z; Fan Y; Hu X; Liu W
    Neurol Sci; 2021 Apr; 42(4):1631-1635. PubMed ID: 33433757
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Value of upper gastrointestinal endoscopy for gastric cancer surveillance in patients with Lynch syndrome.
    Ladigan-Badura S; Vangala DB; Engel C; Bucksch K; Hueneburg R; Perne C; Nattermann J; Steinke-Lange V; Rahner N; Schackert HK; Weitz J; Kloor M; Kuhlkamp J; Nguyen HP; Moeslein G; Strassburg C; Morak M; Holinski-Feder E; Buettner R; Aretz S; Loeffler M; Schmiegel W; Pox C; Schulmann K;
    Int J Cancer; 2021 Jan; 148(1):106-114. PubMed ID: 32930401
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A case of Turcot's syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract: a case report.
    Akabane S; Hinoi T; Akagi K; Yamamoto H; Sada H; Shimizu Y; Shimizu W; Sudo T; Onoe T; Ishiyama K; Suzuki T; Tazawa H; Hadano N; Misumi T; Kojima M; Kubota H; Taniyama D; Kuraoka K; Tashiro H
    BMC Med Genet; 2020 Jul; 21(1):141. PubMed ID: 32611331
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer-risk by family history and mismatch-repair mutation in Lynch syndrome.
    Marques-de-Sá I; Castro R; Pita I; Dinis-Ribeiro M; Brandão C
    Scand J Gastroenterol; 2020 Jun; 55(6):701-705. PubMed ID: 32448028
    [No Abstract]    [Full Text] [Related]  

  • 11. [Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients].
    Hüneburg R; Aretz S; Büttner R; Daum S; Engel C; Fechner G; Habermann JK; Heling D; Hoffmann K; Holinski-Feder E; Kloor M; von Knebel-Döberitz M; Loeffler M; Möslein G; Perne C; Redler S; Rieß O; Schmiegel W; Seufferlein T; Siebers-Renelt U; Steinke-Lange V; Tecklenburg J; Vangala D; Vilz T; Weitz J; Wiedenmann B; Strassburg CP; Nattermann J
    Z Gastroenterol; 2019 Nov; 57(11):1309-1320. PubMed ID: 31739377
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Importance of gastric cancer for the diagnosis and surveillance of Japanese Lynch syndrome patients.
    Ikenoue T; Arai M; Ishioka C; Iwama T; Kaneko S; Matsubara N; Moriya Y; Nomizu T; Sugano K; Tamura K; Tomita N; Yoshida T; Sugihara K; Naruse H; Yamaguchi K; Nojima M; Nakamura Y; Furukawa Y;
    J Hum Genet; 2019 Dec; 64(12):1187-1194. PubMed ID: 31588121
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. An Update on Inherited Colon cancer and Gastrointestinal Polyposis.
    Plevová P
    Klin Onkol; 2019; 32(Supplementum2):97-108. PubMed ID: 31409085
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Molecular characterization of gastric-type endocervical adenocarcinoma using next-generation sequencing.
    Garg S; Nagaria TS; Clarke B; Freedman O; Khan Z; Schwock J; Bernardini MQ; Oza AM; Han K; Smith AC; Stockley TL; Rouzbahman M
    Mod Pathol; 2019 Dec; 32(12):1823-1833. PubMed ID: 31308508
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient.
    Chen X; Li X; Liang H; Wei L; Cui Q; Yao M; Wu X
    Mol Genet Genomic Med; 2019 Aug; 7(8):e787. PubMed ID: 31207149
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Targeted cancer Next-Generation Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract cancers.
    Christakis AG; Papke DJ; Nowak JA; Yurgelun MB; Agoston AT; Lindeman NI; MacConaill LE; Sholl LM; Dong F
    Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1246-1251. PubMed ID: 31028081
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A frameshift mutation in exon 19 of MLH1 in a Chinese Lynch syndrome family: a pedigree study.
    Sui QQ; Jiang W; Wu XD; Ling YH; Pan ZZ; Ding PR
    J Zhejiang Univ Sci B; 2019 Jan.; 20(1):105-108. PubMed ID: 30614234
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review.
    Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K
    BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor development in Japanese patients with Lynch syndrome.
    Saita C; Yamaguchi T; Horiguchi SI; Yamada R; Takao M; Iijima T; Wakaume R; Aruga T; Tabata T; Koizumi K
    PLoS One; 2018; 13(4):e0195572. PubMed ID: 29672549
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prevalence and characteristics of hereditary non-polyposis colorectal cancer (hnpcc) syndrome in immigrant Asian colorectal cancer patients.
    Lee J; Xiao YY; Sun YY; Balderacchi J; Clark B; Desani J; Kumar V; Saverimuthu A; Win KT; Huang Y; Xu Y
    BMC Cancer; 2017 Dec; 17(1):843. PubMed ID: 29237405
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.